- slowrambler
- Sex: M
- Data Quality: 2 stars
- MS: 36 yrs
- Type: Secondary Progressive
- Sensation: Severe
- Overall: Mild
- Cognition: none
- Vision: none
- Speech: none
- Swallowing: none
- Upper limb: none
- Walking: severe
- slowrambler
- Male, 58 years
- Apalachin, NY
- Primary Condition
- MS
- Type
- Secondary Progressive
- First symptom
- 07/75
- Diagnosis
- 09/75
Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.
slowrambler's Dalfampridine (4-AP extended release) is for:
- Nerve pain (neuralgia)
- MS
- Improve mobility
slowrambler has not reported any side effects for Dalfampridine (4-AP extended release).
| As needed Aug 08, 2008 - Jan 14, 2009 | |
| As needed Jan 14, 2009 - Jan 24, 2011 | |
| Stopped Other Jan 24, 2011 |
| Date | Dosage | Improve mobility Efficacy | Nerve pain (neuralgia) Efficacy | MS (Multiple Sclerosis) Efficacy | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|---|---|
| Jan 24, 2011 | As needed |
 
|
|
|
|
|
|
| Feb 09, 2009 | As needed |
|
|
|
|
|
- Date
- Jan 24, 2011
- Advice & Tips
- I took this med as a a means of improving my walking speed as was it's intended purpose. I had to resort to finding a compounding pharmacy to formulate this perscription for me as it took forever (as usual) for the FDA to finally approve ACORDA's version of it (Ampyra). I did enjoy some additional un-expected benefits while using the 4-AP, the 1st being an increased tolerance to heat & the 2nd some minor but definitely noticable reduction in chronic pain. The 4-AP served me very well for the entire length of time that I used it & I incurred no negative side effects.
- Cost: $100-199 monthly
Back to
slowrambler's Profile